Event JSON
{
"id": "cf499d04b877cf1c5037bcb2008908e98186de41499472760e9061e57d0f8319",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1739272469,
"kind": 1,
"tags": [
[
"r",
"https://www.wsj.com/health/health-care-roundup-market-talk-ae766530?siteid=yhoof2\u0026yptr=yahoo"
],
[
"subject",
"Health Care Roundup: Market Talk"
],
[
"published_at",
"1739269440"
],
[
"image",
"https://images.wsj.net/im-27005043/social"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://images.wsj.net/im-27005043/social"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"Top Glove's earnings are expected to recover this year due to the US tariff hikes on Chinese goods, which could lead to US distributors switching to Malaysian manufacturers. Analyst Jack Goh believes the current risk-reward tradeoff is fair, providing upside based on 2026 valuations. UOB Kay Hian maintains a hold rating and target price of MYR1.31 for the stock."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r\nhttps://images.wsj.net/im-27005043/social\n\nhttps://www.wsj.com/health/health-care-roundup-market-talk-ae766530?siteid=yhoof2\u0026yptr=yahoo",
"sig": "a360de930531ec28fac419fcc555a72972bc8016cec8c449bfbe02b23f446d9f0191b733558e67bcdcd8f3909f202fb6194441afa09d1c5e90a4324446404da6"
}